Solid Biosciences (SLDB.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Nov4

Sami Corwin Grants SGT-003 Therapy of Solid Biosciences a Buy Rating

10:51

Analyst Wang and Chardan Capital Maintain Buy Rating on Solid Biosciences

07:56

Livshits Maintains Buy Rating on Solid Biosciences

07:56

Solid Biosciences released FY2025 Q3 earnings on November 3 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD 0 (forecast USD -0.4329)

04:00

Solid Biosciences released FY2025 9 Months Earnings on November 3, 2025 (EST), with actual revenue of USD 0 and actual EPS of USD -1.4963

04:00

Oct13

Corwin Recommends Healthcare Industry Stocks

19:36

Schedules & Filings

Schedules

Filings

Nov3

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -45.78 M, EPS -0.4848

Aug12

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -39.48 M, EPS -0.4193

May15

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -39.28 M, EPS -0.5921

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change